🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective randomized controlled study to evaluated the efficacy...
Status
Completed
Location
Rheumatology Department, the Third Affiliated Hospital of Sun Yat-sen University
Start Date
2008-01
Trial ID
NCT00953979
Treatments Being Tested
Under placebo control, the investigators intend to evaluate the effectivene...
Status
Unknown
Location
Renji Hospital
Start Date
2020-08-01
Trial ID
NCT04528056
Treatments Being Tested
The purpose of this study is to verify the superiority of ASP015K in combin...
Status
Completed
Location
Site CN00048
Start Date
2018-09-27
Trial ID
NCT03660059
Treatments Being Tested
The objective of the study is to establish a prospective disease registry f...
Status
Recruiting
Location
Seattle Children's Hospital
Start Date
2018-08-01
Trial ID
NCT04725422
The purpose of this study is to examine whether the blood test Hemoglobin A...
Status
Recruiting
Location
Medical Diagnostic Center
Start Date
2026-03-10
Trial ID
NCT07416656
Prospective, multicenter, randomized clinical trial, Follow-up at 1-, 6- an...
Status
Completed
Location
Medizinische Universität Graz
Start Date
2005-07
Trial ID
NCT00572494
Treatments Being Tested
Experimental studies suggest that systemic inflammation leads to endothelia...
Status
Completed
Location
Boston Medical Center
Start Date
2003-07
Trial ID
NCT00554203
Treatments Being Tested
This Phase 3, randomized, open-label, multicenter study in rheumatoid arthr...
Status
Terminated
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00521924
RATIONALE: Sulfasalazine may relieve diarrhea in patients with cancer who a...
Status
Completed
Location
Mayo Clinic Hospital
Start Date
2011-04
Trial ID
NCT01198145
Treatments Being Tested
Primary Objective: To assess, in the same study, the safety of sarilumab a...
Status
Completed
Location
Investigational Site Number 840152
Start Date
2013-03
Trial ID
NCT01768572